- Home
- INSG vs THTX Comparison
INSG vs THTX Comparison
Compare INSG & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSG
- THTX
- Stock Information
- Founded
- INSG 1996
- THTX 1993
- Country
- INSG United States
- THTX Canada
- Employees
- INSG N/A
- THTX N/A
- Industry
- INSG Telecommunications Equipment
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- INSG Telecommunications
- THTX Health Care
- Exchange
- INSG Nasdaq
- THTX Nasdaq
- Market Cap
- INSG 111.5M
- THTX 118.2M
- IPO Year
- INSG 2000
- THTX N/A
- Fundamental
- Price
- INSG $8.48
- THTX $2.74
- Analyst Decision
- INSG Buy
- THTX Hold
- Analyst Count
- INSG 3
- THTX 1
- Target Price
- INSG $13.00
- THTX N/A
- AVG Volume (30 Days)
- INSG 87.2K
- THTX 6.2M
- Earning Date
- INSG 05-08-2025
- THTX 04-09-2025
- Dividend Yield
- INSG N/A
- THTX N/A
- EPS Growth
- INSG N/A
- THTX N/A
- EPS
- INSG 0.10
- THTX N/A
- Revenue
- INSG $191,244,000.00
- THTX $88,666,000.00
- Revenue This Year
- INSG $2.53
- THTX N/A
- Revenue Next Year
- INSG $11.55
- THTX $15.13
- P/E Ratio
- INSG $81.58
- THTX N/A
- Revenue Growth
- INSG 14.32
- THTX 13.52
- 52 Week Low
- INSG $3.70
- THTX $1.08
- 52 Week High
- INSG $20.67
- THTX $3.13
- Technical
- Relative Strength Index (RSI)
- INSG 53.95
- THTX 64.04
- Support Level
- INSG $8.00
- THTX $2.64
- Resistance Level
- INSG $8.60
- THTX $2.97
- Average True Range (ATR)
- INSG 0.44
- THTX 0.16
- MACD
- INSG 0.13
- THTX -0.03
- Stochastic Oscillator
- INSG 81.16
- THTX 56.60
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.